MassDevice Q&A

June 30, 2009 by MassDevice staff

Q&A Features

07/16/2013 by Arezu Sarvestani

Glooko CEO Rick Altinger tells that the future of chronic disease management depends on patient engagement, smarter mobile technologies and industry partnerships.

Glooko's diabetes management system

Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.

Just last month,...

06/27/2013 by Brian Johnson

Medtronic CEO Omar Ishrak speaks with publisher Brian Johnson about an evolving global medical device landscape, the shifting values of consumers and why he’s not too worried about fighting the medical device tax.

An Evening With Omar Ishrak

Since taking over 2 year ago, Medtronic (NYSE:MDT) CEO Omar Ishrak has become something akin to the medical device industry version of American...

06/27/2013 by Arezu Sarvestani

Legal analyst Kristian Werling updates on the 2.3% medical device tax, detailing provisions that are still catching the industry off-guard and explaining why price increases aren't as easy as they sound. coverage of the medical device tax, with analyst Kristian Werling

The 2.3% medical device tax has been in effect for about half a year now, meaning some of the myths about the levy are being slowly stripped away.

As it turns out, the retail exemption contained in the IRS codes, protecting over-the-counter...

06/03/2013 by Brian Johnson

Allergan CEO David Pyott talks Botox, medical devices and the aesthetics industry in this podcast, recorded at the MassDevice Big 100 West.

Allergan (NYSE:AGN) CEO David Pyott likes to describe himself as a "mountaineer," a "born marketer," and a bit of a masochist, but there's 1 thing the man undoubtedly is: A great interview.

In this podcast, the 2nd of several we'll be releasing as we...

05/27/2013 by Brian Johnson

Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East

Click to play podcast

Maybe the only mistake Boston Scientific (NYSE:BSX) made when they hired Michael Mahoney as CEO was waiting so long to do it.

After spending much of the last half...

05/02/2013 by Arezu Sarvestani

Sanovas' new MicroCam plug-and-play endoscopic imaging system paves the way for a paradigm shift toward linear medical devices for natural orifice surgery, CEO Larry Gerrans tells

Sanovas CEO Larry Gerrans and the MicroCam technology

In talking about his company's newly launched MicroCam laparoscopic imaging platform, Sanovas CEO Larry Gerrans tells a story of innovation and, perhaps more importantly, of evolution.

In an interview with, Gerrans described the "plug-&-play...

Syndicate content
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp